Selinexor (KPT-330) in Older Patients With Relapsed AML

Clinical trial NCT02088541 · COMPLETED

Trial details

NCT number: NCT02088541
Sponsor: Karyopharm Therapeutics Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)

Start date: 2014-03-01
Primary completion: 2018-01-08
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.